1/ A viral post claims Brian Hooker, PhD, established that the only Amish people with autism were children vaccinated before being adopted—and that there are “zero” cases among unvaccinated Amish-born children.

He established no such thing.

The clip being recirculated in July 2026 comes from a July 15, 2025 Senate hearing. Hooker’s written testimony identifies him as the chief scientific officer of Children’s Health Defense.

A Senate microphone does not turn an unsupported assertion into epidemiology.

Sources: Official Senate hearing⁠,

hsgac.senate.gov/subcommittees/…

Hooker’s written testimony⁠.

hsgac.senate.gov/wp-content/upl… 2/ The story is largely recycled from journalist Dan Olmsted’s 2005 “Amish anomaly” columns.

Olmsted went to Lancaster County, asked local contacts whether they knew autistic Amish people, and emphasized an adopted child who had previously been vaccinated.

That might generate a hypothesis. It cannot estimate prevalence or establish causation.

There was no representative sampling frame, comprehensive case-finding system, standardized diagnostic assessment, matched comparison group or verified individual exposure history.

“I did not find them by asking around” does not mean “they do not exist.”

Sources: Archived Olmsted series⁠, 1796web.com/pdfs/Amish_ano… history and assessment of the claim⁠. fullfact.org/health/amish-a…

1/4 Brian Hooker and Karl Jablonowski claim 2-month vaccination made infants “more likely to die” at 3 months.

But how could this withdrawn preprint estimate mortality when every analyzed child had died before age 3—and no living comparison group existed?
zenodo.org/records/182629… 2/4 Why were children who died after day 120 classified as “alive”? Why was a child called “unvaccinated” merely because no listed dose appeared during days 60–90? And why were roughly 69% of death records left unlinked without showing whether linkage biased the sample?

1/ Long COVID: A Heterogeneous Clinical Syndrome

The first mistake is treating Long COVID as one tidy disease.

It is better understood as a heterogeneous post-infectious clinical syndrome.

Patients may present with very different dominant patterns:

fatigue and post-exertional malaise
cognitive dysfunction
dysautonomia or POTS-like symptoms
cardiopulmonary complaints
sleep disturbance
pain
GI symptoms
multisystem impairment

Those patterns can overlap.

But “Long COVID” alone does not tell you which pathway is dominant, which systems are involved, or which management strategy is most appropriate.

Not one disease.
Not one mechanism.
Not one clinical pathway.

That is the starting point. 2/ Definitions Matter

Definitions matter because they shape diagnosis, research, prevalence estimates, disability decisions, and clinical care.

WHO, CDC, and the National Academies all recognize Long COVID / post-COVID condition, but their frameworks are not identical.

WHO emphasizes symptoms usually beginning within 3 months, lasting at least 2 months, and not being explained by another diagnosis.

CDC frames Long COVID as a chronic condition after SARS-CoV-2 infection, present for at least 3 months, affecting one or more organ systems.

The National Academies describe Long COVID as a chronic, systemic disease state that can be continuous, relapsing-remitting, or progressive.

The clinical implication:

Long COVID remains a clinical diagnosis.

There is no single validated biomarker.

And definition clarity helps prevent both underdiagnosis and overdiagnosis.

New paper review:

A Nature study mapped self-reported sleep duration against 23 biological ageing clocks across MRI, plasma proteomics, and metabolomics in UK Biobank.

The finding was not simply “sleep matters.”

It was more interesting:

Sleep duration showed a U-shaped association with several biological age gaps across multiple organ systems. Short sleep and long sleep both tracked with higher ageing signatures, disease risk, and all-cause mortality.

But this is not a prescription to sleep exactly 7 hours.

It is an observational, population-level study. It shows associations, not proof that changing sleep duration reverses ageing clocks or prevents disease.

Best takeaway:

Persistent short sleep—or unexplained long sleep—may be a meaningful systemic health signal worth investigating in context. 1/ A new Nature paper asks a deceptively simple question:

Is sleep duration associated with biological ageing across the body?

Not just “brain age.”
Not just mortality curves.
Not just one biomarker.

The authors mapped self-reported sleep duration against 23 biological ageing clocks derived from MRI, plasma proteomics, and metabolomics in UK Biobank.

The headline finding: a U-shaped pattern.

In several organ systems, both short sleep and long sleep were associated with higher biological age gaps, while the lowest fitted ageing burden tended to sit around ~6.4–7.8 hours.

Important caveat: this does not mean everyone has a precise “ideal” sleep number. These are sample-specific fitted minima, not personalized prescriptions.

1/ Antivax claim: “mRNA COVID vaccines are gene therapy.”

No. That confuses “genetic instructions” with “gene therapy.”

mRNA vaccines deliver a temporary RNA message that helps cells make a viral protein fragment so the immune system can learn to recognize SARS-CoV-2. They do not modify your genes. 2/ The key distinction:
DNA = the long-term genetic archive, stored in the nucleus.

mRNA = a short-lived working copy used by cells to make proteins.

COVID mRNA vaccines stay outside the nucleus, use the cell’s protein-making machinery, and are then broken down.

They do not enter the nucleus or alter human DNA.

1/ Intro:

This thread is not about whether Joe Rogan should interview controversial people.

It’s about something narrower and more measurable:

Since the COVID pandemic began, Rogan has repeatedly hosted long-form, friendly interviews with prominent anti-vaccine activists, COVID-vaccine skeptics, and alternative-treatment promoters — often with little sustained pushback when unsupported claims were made.

So let’s look guest by guest:
What claims were amplified?
What does the evidence actually say?
And why does “just asking questions” matter when the audience is enormous? 2/ Robert F. Kennedy Jr.

RFK Jr. is not merely “vaccine hesitant.” He has been one of the most prominent anti-vaccine activists in the U.S. for years, including through Children’s Health Defense.

On Rogan, he was given hours to argue that public-health agencies, pharma, regulators, and mainstream scientists are not merely wrong, but structurally corrupt or captured.

The problem: his vaccine claims repeatedly conflict with large bodies of evidence. The vaccine-autism claim remains unsupported by major epidemiologic evidence. His COVID-vaccine claims have also been repeatedly fact-checked as misleading or false.

A long-form interview can make unsupported claims feel like a “side of the debate.” But vaccines are not judged by vibes, anecdotes, or courtroom-style suspicion. They are judged by converging evidence: clinical trials, pharmacovigilance, epidemiology, and expert review.

“What Gain-of-Function Research Actually Is”

“Gain of function” is one of the most misunderstood terms in science. At the broadest level, it simply means changing a biological system so it gains or enhances a trait or activity. That can include ordinary lab work. But in public debate, the phrase usually refers to a much narrower issue: experiments on pathogens that may increase traits like transmissibility, host range, virulence, or immune escape. Those are not the same thing, and a lot of confusion starts right there. 2/ Why do scientists do this kind of research at all? In principle, because studying how pathogens change can help us understand what mutations matter, how viruses adapt, what might threaten humans, and how to design surveillance, vaccines, and treatments. The problem is that this is classic “dual-use” territory: work done for legitimate public-health reasons can also create safety or security risks if the organism, methods, or knowledge are misused or escape containment.

1/ The strongest critique of homeopathy is not simply: “there’s no molecule left.”

That’s true for many high-dilution remedies, but it’s not the deepest problem.

The deeper problem is this:

If homeopathy’s core claims were true, the implications would not be limited to homeopathy.

They would rewrite chemistry, pharmacology, toxicology, manufacturing, clinical trial design, environmental science, and biology itself.

Homeopathy asks us to accept that a substance can become more “potent” as it is serially diluted and shaken — even beyond the point where any molecule of the original substance is likely to remain.

So the real question is not:

“Could one unusual remedy work?”

The real question is:

“What else would have to be true about the universe for this to work?”

And once you follow that logic, the system begins to collapse under its own implications. 2/ Start with “like cures like.”

Homeopathy claims that a substance causing symptoms in a healthy person can treat similar symptoms in a sick person.

But symptoms are not mechanisms.

Fever can come from influenza, malaria, lymphoma, autoimmune disease, drug reactions, heat illness, or sepsis.

Cough can come from asthma, pneumonia, reflux, heart failure, cancer, ACE inhibitors, or post-viral inflammation.

If symptom resemblance were the key therapeutic map, then biology would be organized around pattern-matching rather than causal mechanisms.

That would mean the “symptom image” of a substance matters more than receptors, enzymes, pathogens, immune pathways, tissue injury, pharmacokinetics, or dose-response biology.

But medicine repeatedly shows the opposite.

Insulin works because it replaces a missing hormone signal.

Antibiotics work because they interfere with microbial survival.

Anticoagulants work because they modify coagulation pathways.

Vaccines work because they train adaptive immunity.

Chemotherapy, bronchodilators, antivirals, antihypertensives, and immunotherapies work because they intervene in causal systems.

So if homeopathy were right, much of modern pathophysiology would be secondary to symbolic symptom similarity.

That is not a small claim.

It is a completely different biology.

Homeopathy advocates are framing recent retractions as evidence that “challenging” science is being suppressed.

But for clinicians, the better question is simpler:

Do these studies survive the evidentiary standards we would apply to any biologically implausible claim with real clinical consequences?

A short thread. 1/ The CHD essay on retracted homeopathy studies raises one legitimate issue: retractions should be transparent, proportionate, and procedurally fair.

But that does not rescue the larger argument.

The question is not whether homeopathy papers are “allowed” to report positive findings. They are.

The question is whether extraordinary, biologically implausible claims survive the level of scrutiny appropriate for clinical medicine — especially when the claimed effects involve pediatric illness burden, antibiotic use, cancer quality of life, or survival.

That is where the essay becomes much weaker.

A retraction dispute is not the same thing as evidence of suppression. And a “positive” trial is not the same thing as reliable evidence.

HPV-related health problems are falling — but why?

Some antivaccine voices insist the vaccine deserves little credit, and claim changing sexual behavior explains the trend instead.

This short thread looks at the evidence in probabilistic terms:
• direct vaccine effects
• herd immunity
• behavioral change

The pattern is not random — and it strongly favors vaccination as the primary driver. 1/ Some antivaccine accounts are now arguing:
“HPV-related health problems are falling, but it’s not the vaccine. It’s changing sexual behavior.”
That explanation is possible in a weak, partial sense.
But as the main explanation?
It fails several basic causal tests.
The HPV vaccine explanation fits the evidence far better because the declines are:
• strongest for vaccine-covered HPV types
• strongest in vaccinated birth cohorts
• larger where vaccine coverage is higher
• seen first in HPV infection and genital warts
• later seen in cervical precancer and cervical cancer
• also seen indirectly in some unvaccinated groups, consistent with herd effects
That is not the fingerprint of generic behavior change.
That is the fingerprint of vaccination.

1/ A Substack is circulating the claim that a Norwegian study shows “74% of new myocarditis cases were related to COVID-19 vaccination, while only 4.2% were related to infection.”

That is not what the study shows.

The paper is important because it validates that vaccine-associated myocarditis is real, rare, and concentrated in young males.

But the Substack turns a post-vaccination myocarditis validation study into a population-wide causal claim about all myocarditis in Norway.

That is a denominator error. 2/ What did the Norwegian study actually find?

Researchers reviewed suspected myocarditis cases occurring after COVID-19 mRNA vaccination in Norway.

Out of 4.1 million vaccinated people, they identified 177 cases where vaccination was considered the most likely cause.

That equals about 4.5 cases per 100,000 vaccinated individuals.

That is clinically meaningful.

It is not “nothing.”

But it is also not evidence that vaccines caused 74% of Norway’s myocarditis burden.

The study question was not:

“Among all myocarditis cases in Norway, what percentage was caused by vaccines vs infection?”

The study question was closer to:

“Among reported post-vaccination myocarditis cases, how many are clinically validated and likely vaccine-associated?”

1/ For centuries, the debate focused on a question we now know the answer to:

Did Vikings reach North America before Columbus?

Yes.

Not only did Norse sailors reach North America nearly 500 years earlier, archaeological evidence now suggests they may have returned repeatedly for generations.

The more interesting question is no longer whether they came.

It is why so little of their presence appears to have survived.

Recent work from archaeology, dendrochronology, and population genetics points toward one of the most unusual episodes in human migration history:

A sustained trans-Atlantic connection that left remarkably little biological legacy. 2/ The story begins in Greenland.

When Erik the Red established Norse settlements there around 985 CE, the colonists faced an ecological problem that threatened their survival.

Greenland had grazing land.

It had fjords.

It had walrus ivory.

What it did not have was timber.

And timber was the strategic resource of Viking civilization.

Ships, homes, churches, tools, furniture, agricultural equipment—everything depended on wood.

Yet Greenland possessed almost no forests capable of supporting shipbuilding.

The question becomes unavoidable:

How did a maritime civilization survive for centuries in a place with almost no trees?

For decades, cortisol has been portrayed as the villain of modern health.

The hormone that makes us gain weight.
The hormone that causes anxiety.
The hormone that destroys sleep.

But that story is incomplete.

Cortisol is one of the body’s most important survival signals. It helps regulate energy, immunity, metabolism, cardiovascular function, behavior, and recovery. Without it, life is not possible.

The real question isn’t whether cortisol is “good” or “bad.”

The question is:

What is the body trying to accomplish when cortisol rises?

In this thread, we’ll move beyond the outdated “stress hormone” narrative and explore cortisol through the lens of modern neuroscience, predictive processing, allostasis, metabolism, exercise, obesity, food noise, depression, Long COVID, and aging.

Because cortisol isn’t simply a stress hormone.

It’s a resource-allocation hormone helping the body navigate uncertainty. 1/ Cortisol’s Original Job

Cortisol did not evolve to make people anxious, gain weight, or struggle with sleep.

Its original purpose was survival.

For most of human history, threats were tangible: hunger, injury, infection, predators, cold, and uncertainty about where the next meal would come from. When the brain detected those challenges, cortisol helped mobilize energy, maintain blood pressure, sharpen attention, and prioritize immediate survival.

The problem is that modern humans still possess the same biological alarm system.

Today, the “predator” may be financial stress, job insecurity, relationship conflict, social isolation, or constant digital stimulation. Yet the nervous system often responds as though survival itself is at stake.

Cortisol is not a design flaw. It is an ancient adaptation trying to solve modern problems.

GLP-1 drugs may be the most consequential medications of the last decade.

Originally developed for diabetes, they are now showing effects on appetite, cardiovascular disease, inflammation, fatty liver disease, kidney health, sleep apnea, and even behaviors linked to addiction and reward.

But the deeper scientists look, the stranger the story becomes.

What exactly are these drugs doing—and what do they reveal about hunger, metabolism, and human desire itself?

A short 🧵

@IntegralAnswers 1/ One of the most striking ideas from Ezra Klein’s conversation with Julia Belluz is that GLP-1 drugs may be teaching us something profound about obesity:

Hunger is not simply a stomach problem. It is a brain process.

Many people describe living with constant “food noise”—persistent thoughts about food, cravings, and the mental effort required to resist them. When GLP-1 drugs work, that noise often becomes dramatically quieter.

For some patients, the experience is revelatory. The issue was never a lack of character or willpower. The biological drive itself has changed.

That observation challenges decades of cultural assumptions about obesity. If a medication can make resisting food feel effortless for one person while another must fight cravings every waking hour, then physiology may play a much larger role than society has been willing to acknowledge.

As Belluz notes, genetics, neurobiology, environment, sleep, stress, and food availability all interact to shape behavior.

The implication is uncomfortable but important:

Many people judged for lacking discipline may actually be fighting biological forces that others never experience.

Most people read a study the same way:

Read the abstract.

Skim the conclusion.

Accept the authors’ interpretation.

Move on.

The problem is that scientific papers contain far more than conclusions. They contain assumptions, methodological choices, statistical decisions, limitations, competing explanations, and uncertainties that may dramatically affect how the findings should be interpreted.

Over the years I’ve found that many disagreements about science don’t arise because people are looking at different data. They arise because they’re evaluating the same paper through very different lenses.

To improve the quality of my own reviews, I began using a structured evidence-review framework inspired by principles of evidence-based medicine, peer review, critical appraisal, and scientific skepticism.

The objective is not to prove a study right.

The objective is not to prove a study wrong.

The objective is to determine what the evidence can legitimately support.

This framework forces me to separate:

• What was studied
• What was claimed
• What the methods can support
• What the results actually show
• What remains uncertain

The process also helps guard against some of the most common errors in science communication:

• Narrative over numbers
• Claim inflation
• Correlation presented as causation
• Ignoring alternative explanations
• Overgeneralization beyond the study population
• Confusing statistical significance with clinical significance

The following visual cards outline the exact framework I use when reviewing medical studies, preprints, essays, Substack articles, and scientific claims before creating public-facing content.

Strong conclusions require strong evidence.

And perhaps the most important question in all of science remains:

“What observation would convince you that your hypothesis is wrong?”

🧵 1/ Phase 1: Structural Extraction

1/15

LONG COVID TREATMENTS:
Evidence, Management, and Uncertainty

Long COVID is not one disease with one treatment.

It is a heterogeneous, multi-system condition likely involving overlapping biological processes including immune dysregulation, autonomic dysfunction, viral persistence, endothelial injury, metabolic impairment, and neuroinflammation.

That complexity explains why:
• no universal cure exists
• responses vary dramatically
• many therapies remain investigational

What does appear increasingly clear:

The best outcomes usually come from individualized, multi-system, symptom-guided care rather than one-size-fits-all protocols.

This thread explores:
• what appears clinically useful
• what remains uncertain
• what is promising but still speculative 2/15

WHY IS TREATMENT SO DIFFICULT?

Long COVID is biologically complex and highly variable between patients.

Major challenges include:
• no validated diagnostic biomarker
• fluctuating symptoms
• multiple overlapping mechanisms
• phenotype/endotype variability
• different organ systems involved simultaneously

Two patients may both have “Long COVID” while sharing very little biologically.

This creates enormous difficulty for:
• clinical trials
• patient stratification
• treatment matching
• outcome measurement

What we do know:
• PEM (post-exertional malaise) is real and clinically important
• autonomic dysfunction is common
• multi-system involvement is frequent
• symptom burden can be disabling
• individualized care matters

The future likely depends on identifying biologic subtypes and matching therapies accordingly.

What if one silent biological process was quietly increasing the risk of heart disease, Alzheimer’s, diabetes, autoimmune disease — and even some cancers?

Not years from now.

Right now.

A thread on chronic inflammation and why it matters more than most people realize.
@IntegralAnswers 1/ Chronic inflammation may be one of the most important hidden drivers of modern disease.

Not the inflammation you feel after an injury.

The silent kind that damages blood vessels, metabolism, DNA, and organs for years before symptoms appear.

Based on a lecture by Dr. Ameen Hedayat.

1/ A new BMJ systematic review examined human evidence on aluminium adjuvants in vaccines.

This was not a narrative opinion piece. The authors used:
• PRISMA 2020
• PROSPERO registration
• RoB 2.0 / ROBINS-I
• GRADE assessment

BMJ 2026;393:e088921 2/ The review included:
• 11 randomized controlled trials
• 9 cohort studies
• 37 case series
• 2 ecological studies
The authors repeatedly emphasized that study quality matters when interpreting safety claims.

1/ Public health isn’t collapsing because the science failed.

It’s collapsing because we stopped trusting the system designed to interpret that science.

A conversation with Dr. Paul Offit ↓ 2/ We’ve shifted from expert guidance → individual decision-making.

That sounds empowering.

But it fundamentally changes how public health works.

1/ 🚨 Mail-in blood smear tests claiming to detect “amyloid” or “microclots” are gaining traction.

They look scientific.
They sound advanced.

But are they clinically valid?

Let’s break it down. 🧵 2/ The Protocol

The protocol:

• Finger-prick your blood
• Smear on glass
• Let it dry
• Mail internationally

This is NOT how clinical pathology or hematology is performed.

No controlled collection. No standardization.

1/ Long COVID is one of the most complex post-infectious syndromes ever studied.

A new review in Nature Communications Medicine attempts to unify the biology.

Here’s what’s established, what’s emerging, and what’s still speculative. 🧵 2/ The biggest mistake?

Treating Long COVID as a single disease.

The evidence suggests:
→ Multiple overlapping syndromes
→ Different mechanisms in different patients

This explains why studies—and treatments—often conflict.